Physician profile
Robert S Lind
NPI 1609822782
$5,711.22
in general payments reported to CMS, 2019-2025
55 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $264 · 2021: $898 · 2022: $1,050 · 2023: $1,225 · 2024: $766 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,448.13 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $680.75 | 2021-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $521.89 | 2019-2024 | Xarelto |
| Amgen INC. | $367.24 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $325.43 | 2019-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $282.08 | 2019-2024 | |
| Lilly USA, LLC | $256.09 | 2023-2025 | Jardiance, Mounjaro, Trulicity |
| Dexcom, INC. | $246.86 | 2019-2025 | Dexcom G6 Transmitter |
| Atricure, INC. | $229.50 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $189.22 | 2021-2025 | Watchman, Varithena Administration Pack |
| Pfizer INC. | $175.11 | 2019-2023 | |
| Philips North America LLC | $157.48 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $155.59 | 2019-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $134.55 | 2021-2023 | Verquvo |
| Astellas Pharma US INC | $117.25 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.37 | 2019-2024 | Jardiance |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $112.04 | 2019-2023 | |
| Medtronic Minimed, INC. | $98.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $95.17 | 2019-2023 | |
| Medtronic, INC. | $87.77 | 2022 | |
| Tolmar, INC. | $83.41 | 2024-2025 | Jatenzo |
| Intuity Medical INC | $77.64 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Insulet Corporation | $75.64 | 2023-2025 | Omnipod |
| Currax Pharmaceuticals LLC | $70.76 | 2023-2025 | Contrave |
| Esperion Therapeutics, INC. | $68.58 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $65.37 | 2021-2025 | Isturisa |
| Beta Bionics, INC. | $65.15 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Mannkind Corporation | $62.73 | 2023-2024 | Afrezza |
| Xeris Pharmaceuticals, INC. | $62.49 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.37 | 2019-2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $59.84 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $57.82 | 2019-2023 | Evkeeza |
| Becton, Dickinson and Company | $56.32 | 2019-2022 | |
| Daiichi Sankyo INC. | $50.95 | 2023 | Injectafer |
| Novo Nordisk INC | $45.23 | 2019-2024 | Wegovy, Ozempic |
| Kowa Pharmaceuticals America, INC. | $37.02 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $31.94 | 2021 | |
| Amryt Pharma Holdings LTD | $28.97 | 2023 | Mycapssa |
| Kestra Medical Technology Services, INC. | $28.94 | 2022 | |
| Inspire Medical Systems, INC. | $24.25 | 2023 | Inspire |
| Abbott Laboratories | $23.14 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Acella Pharmaceuticals, LLC | $20.04 | 2023 | NP Thyroid 60 |
| Ascendis Pharma Endocrinology INC | $18.13 | 2025 | Yorvipath |
| Acerus Pharmaceuticals Corporation | $17.83 | 2020 | |
| Azurity Pharmaceuticals, INC. | $16.03 | 2024 | Edarbi |
| Kiniksa Pharmaceuticals, LTD. | $15.96 | 2023 | Arcalyst |
| Amphastar Pharmaceuticals, INC. | $15.93 | 2024 | |
| Embecta Corp. | $15.74 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Lifescan, INC. | $15.38 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $14.97 | 2022 | |
| Lundbeck LLC | $14.11 | 2019 | |
| Horizon Therapeutics Plc | $12.72 | 2022 | |
| Altathera Pharmaceuticals LLC | $12.59 | 2024 | Sotalol Hydrochloride |
| Arbor Pharmaceuticals, INC. | $12.55 | 2021 | |
| Eisai INC. | $12.54 | 2019 | |
| Vifor Pharma, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.